Stock screener

PVLA

Conviction 56HealthcareScan · Thu, Sep 24, 2026

Palvella Therapeutics, Inc. (PVLA) closed at $146.12 (-2.30%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 44, RS Rating 96, -7.6% from its 52-week high, +45.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

PVLA$146.12-2.30%
ResistanceSupportVol 14Insider sell
63 bars
3
3
3
5
4
Vol MA14 229.01K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
PALVELLA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.palvellatx.com ↗
Price146.12
Change-2.30%
Gap-0.10%
Rel volume—
Avg volume218.58K
Avg $ vol33.18M
SMA 20151.98
SMA 50149.48
SMA 200122.56
Price vs 50-2.25%
Price vs 200+19.22%
MA stackmixed
50/200 cross—
Supertrendup · 138.79
RSI (14)44
MACD hist-0.60
MACD crossbear · 1d
Stoch %K / %D15 / 41
ADX (14)9
+DI / −DI17 / 23
RSI divergence—
MACD divergence—
ATR %4.66%
ADR %3.92%
52w high158.13
52w low57.69
From 52w high-7.60%
Above 52w low+153.28%
New 52w highNo
SqueezeOn · 26d
Bollinger width7.08%
%B-0.04
Donchian pos15.35%
Donchian high160.84
Donchian low143.45
AVWAP (52w high)148.31
vs AVWAP high-1.48%
AVWAP (52w low)113.88
vs AVWAP low+28.32%
OBV trendDown
Chaikin MF (20)-0.07
Today vs 20d—
Avg vol (14d)229.01K
Avg vol (20d)218.58K
Avg $ vol (20d)33.18M
Market cap2.11B
RS Rating96 / 99
RS 3m (vs SPY)+2.79%
RS 6m (vs SPY)+4.55%
RS line new highNo
Trend template7/8
Technical rank68.2
1 week-5.31%
1 month-1.43%
3 months+7.28%
6 months+21.37%
1 year+157.75%
YTD+45.71%
P/E-50.47
P/B9.71
P/S48.24
P/FCF-83.62
EPS-3.71
Div yield—
ROE-19.24%
ROA-16.46%
Debt/Eq—
Current21.18
EV/EBITDA-52.25
Gross margin—
Net margin-95.58%
Rev growth60.18%
EPS growth-139.27%
Price target235.22
Target upside60.98%
Analyst ratingBuy
Institutional101.71%
Ent. value1.92B
Revenue14.5M
Net income-21.87M
Gross profit—
Free cash flow-25.18M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out14.34M
Employees29
ListedMon, Dec 16, 2024
Free float8.97M
Float %75.8%
Short interest2.29M
Days to cover11.1d
Short volume49.5%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.52 vs −$1.16
Last surprise-31.0% miss
Setup gradeC
Conviction56 / 100
Pattern quality—
Tech rank68.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance160.55
Support135.68
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PVLA

All disclosures →
No recent disclosed trades by Congress in PVLA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PVLA · open-market 9 sells

InsiderSideShares
JENKINS GEORGE M
Director · Common Stock · 2026-09-15
Sell560
JENKINS GEORGE M
Director · Common Stock · 2026-09-15
Sell263
JENKINS GEORGE M
Director · Common Stock · 2026-09-15
Sell954
JENKINS GEORGE M
Director · Common Stock · 2026-09-14
Sell1.56K
JENKINS GEORGE M
Director · Common Stock · 2026-09-14
Sell5.63K
JENKINS GEORGE M
Director · Common Stock · 2026-09-14
Sell6.16K
JENKINS GEORGE M
Director · Common Stock · 2026-09-11
Sell4.58K
JENKINS GEORGE M
Director · Common Stock · 2026-09-11
Sell6.52K
JENKINS GEORGE M
Director · Common Stock · 2026-09-11
Sell1.27K
Goin Kathleen
Chief Operating Officer · Stock Option (Right to Buy) · 2026-08-19
Exercise2.15K

SEC filings

EDGAR filings in PVLA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.